May 19, 2022

Yield10 Bioscience to Present at the H.C. Wainwright Global Hybrid Investment Conference

WOBURN, Mass. –May 19, 2022 – Yield10 Bioscience, Inc. (Nasdaq: YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that President and CEO Oliver Peoples, Ph.D. will present a corporate overview at the H.C. Wainwright Global Hybrid Investment Conference. The conference is being held on May 23 – 26, 2022 at the Fontainebleau Hotel in Miami Beach, FL.


Event:  H.C. Wainwright Global Hybrid Investment Conference

Time:  Available on demand as of 7:00 am ET May 24 through May 26, 2022

Webcast: Click this link to view the presentation  

About Yield10 Bioscience

Yield10 Bioscience, Inc. is an agricultural bioscience company that is using its differentiated trait gene discovery platform, the “Trait Factory”, to develop improved Camelina varieties to produce proprietary seed products, and to discover high value genetic traits for the agriculture and food industries. Our goals are to efficiently establish a high value seed products business based on developing superior varieties of Camelina for the production of feedstock oils for renewable diesel, PHA bioplastics and omega-3 (DHA+EPA) oils, and to license our yield traits to major seed companies for commercialization in major row crops, including corn, soybean and canola. Yield10 is headquartered in Woburn, MA and has an Oilseeds Center of Excellence in Saskatoon, Canada.

For more information about the Company, please visit, or follow the Company on Twitter, Facebook and LinkedIn.




Lynne H. Brum, (617) 682-4693,


Investor Relations:  

Bret Shapiro, (561) 479-8566,

Managing Director, CORE IR


Media Inquiries:

Eric Fischgrund,

FischTank PR